PETER LIN to Hyperplasia
This is a "connection" page, showing publications PETER LIN has written about Hyperplasia.
Connection Strength
0.418
-
Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model. Ann Vasc Surg. 2018 May; 49:295-303.
Score: 0.142
-
Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg. 2004 Jun; 39(6):1322-8.
Score: 0.056
-
Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. J Surg Res. 2004 May 01; 118(1):45-52.
Score: 0.055
-
Carotid stenting using heparin-coated balloon-expandable stent reduces intimal hyperplasia in a baboon model. J Surg Res. 2003 Jun 01; 112(1):84-90.
Score: 0.052
-
Heparin-coated balloon-expandable stent reduces intimal hyperplasia in the iliac artery in baboons. J Vasc Interv Radiol. 2003 May; 14(5):603-11.
Score: 0.052
-
Ginkgolide A-gold nanoparticles inhibit vascular smooth muscle proliferation and migration in vitro and reduce neointimal hyperplasia in a mouse model. J Surg Res. 2011 Nov; 171(1):31-9.
Score: 0.022
-
miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn. 2011 Jan; 11(1):79-89.
Score: 0.022
-
Mouse models of neointimal hyperplasia: techniques and applications. Med Sci Monit. 2006 Sep; 12(9):RA177-85.
Score: 0.016